Stay updated on Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin
Sign up to get notified when there's something new on the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page.

Latest updates to the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page
- Check6 days agoChange DetectedThe ClinicalTrials.gov revision label in the footer changed from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA banner was added announcing an NIH website terminology transition, and the site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with a minimal error screen and navigation footer, indicating restricted access to the record.SummaryDifference18%

- Check55 days agoChange DetectedThe revision tag on the page has been updated from v3.6.6 to v3.7.0, indicating a software update to the interface. This change does not alter the displayed study details or data on the page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision label was updated to Revision: v3.6.6, signaling a new build of the page.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page.